Pretreatment clinical and genetic factors predict early post-treatment mortality in fit AML patients following induction

J. Erika Haydu, Yael Flamand, Rahul S. Vedula, Jurjen Versluis, Anne Charles, Kevin M. Copson, Richard M. Stone, Daniel J. DeAngelo, Donna Neuberg, R. Coleman Lindsley, Marlise R. Luskin*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)E259-E262
JournalAmerican Journal of Hematology
Volume96
Issue number7
DOIs
Publication statusPublished - Jul 2021
Externally publishedYes

Bibliographical note

Funding Information:
This work was supported by funding from the NIH (1K08CA204734) and the James A. and Lois J. Champy Family Fund (R.C.L.).

Cite this